LIGAND PHARMACEUTICALS INC (LGND) › Net IncomeLIGAND PHARMACEUTICALS INC (LGND) — Net IncomeAnnual figures by fiscal year, from SEC filings.2009: -$1.95M2010: -$10.37M2011: $9.71M2012: -$527.0K2013: $11.42M2014: $12.02M2015: $229.82M2016: -$1.64M2017: $12.56M2018: $143.32M2019: $629.30M2020: -$2.98M2021: $57.14M2022: -$33.36M2023: $52.15M2024: -$4.03M2025: $124.45M$124.45M2009Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025$124.45M+3186.6%2024-$4.03M-107.7%2023$52.15M+256.3%2022-$33.36M-158.4%2021$57.14M+2014.2%2020-$2.98M-100.5%2019$629.30M+339.1%2018$143.32M+1041.5%2017$12.56M+867.5%2016-$1.64M-100.7%2015$229.82M+1811.4%2014$12.02M+5.3%2013$11.42M+2267.0%2012-$527.0K-105.4%2011$9.71M+193.7%2010-$10.37M-432.5%2009-$1.95M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share